Creating a stakeholder engagement plan: Perspectives Learned from the USDeN
March 14, 2023 at 2PM ET | 11AM PT Presenter(s): Drs. Nicole Brandt, Catherine Sarkisian, and Ms. Carmen Reyes Description: Hear first-hand from the USDeN Stakeholder Engagement
How should we better measure the cost-effectiveness of deprescribing interventions? Recommendations for improving value assessment
Hung A, Wang J, Moriarty F, et al. Value assessment of deprescribing interventions: Suggestions for improvement [published online ahead of print, 2023 Feb 21]. J
Complex challenges in pain and opioid management: Relevance to deprescribing
February 27, 2023 at 2PM ET | 11AM PT Presenter: Jessica S. Merlin, MD, PhD, MBA Associate Professor of Medicine at the University of Pittsburgh School
Key learnings from the OPTIMIZE deprescribing pragmatic trial
Sheehan OC, Gleason KS, Bayliss EA, et al. Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trial [published online ahead of
Multiple Comorbidities and Multiple Medications: The Challenges Facing Older Adults with Heart Failure
Kwak MJ, Cheng M, Goyal P, et al. Medication Complexity Among Older Adults with HF: How Can We Assess Better?. Drugs Aging. 2022;39(11):851-861. doi:10.1007/s40266-022-00979-2 Heart
How “age-friendly” are deprescribing interventions?
Wang J, Shen JY, Conwell Y, et al. How “age-friendly” are deprescribing interventions? A scoping review of deprescribing trials [published online ahead of print, 2022
Deintensifying diabetes medications: Beliefs and misconceptions among older adults
Pilla SJ, Meza KA, Schoenborn NL, Boyd CM, Maruthur NM, Chander G. A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications [published
USDeN-Funded Pilot & Grant Planning Award Application Information Session (2023-2024 Cycle)
October 21, 2022 | 2:00 – 3:00 PM Eastern / 11:00 – 12:00 PM Pacific Presenter(s): Drs. Amanda Mixon & Sandra Simmons DOWNLOAD PRESENTATION POWERPOINT (PDF) »
Gabapentin as a substitute for opioids: Is the solution creating new problems?
Bongiovanni T, Gan S, Finlayson E, et al. Prolonged use of newly prescribed gabapentin after surgery [published online ahead of print, 2022 Aug 24]. J
USDeN-Funded CIH Interventions to Support Deprescribing of Benzodiazepine Receptor Agonist Pilot Award Application Information Session
October 11, 2022 | 2:00 – 3:00 PM Eastern / 11:00 – 12:00 PM Pacific Presenter(s): Drs. Amanda Mixon & Sandra Simmons DOWNLOAD PRESENTATION POWERPOINT (PDF) »
